Craig Bijou
Stock Analyst at B of A Securities
(3.75)
# 747
Out of 5,124 analysts
65
Total ratings
58.33%
Success rate
51.97%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Downgrades: Neutral | $55 → $38 | $31.46 | +20.79% | 5 | Dec 8, 2025 | |
| GMED Globus Medical | Upgrades: Buy | $65 → $91 | $87.31 | +4.23% | 5 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Underperform | $18 → $9 | $10.42 | -13.63% | 2 | Jul 9, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $122.04 | +14.72% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $17.08 | -0.47% | 3 | Feb 20, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $12.42 | +44.93% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $78.43 | +84.88% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $88.14 | +16.86% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $80.15 | +6.05% | 1 | Sep 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $82.02 | +4.85% | 2 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $81.96 | +15.91% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $19.72 | +82.56% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $6.72 | +569.64% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $8.64 | +1,288.89% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.49 | +568.90% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $19.02 | -31.65% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $15.16 | +177.04% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $566.36 | -59.39% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $351.47 | -34.56% | 4 | Jul 26, 2019 |
PROCEPT BioRobotics
Dec 8, 2025
Downgrades: Neutral
Price Target: $55 → $38
Current: $31.46
Upside: +20.79%
Globus Medical
Nov 7, 2025
Upgrades: Buy
Price Target: $65 → $91
Current: $87.31
Upside: +4.23%
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $10.42
Upside: -13.63%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $122.04
Upside: +14.72%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $17.08
Upside: -0.47%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $12.42
Upside: +44.93%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $78.43
Upside: +84.88%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $88.14
Upside: +16.86%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $80.15
Upside: +6.05%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $82.02
Upside: +4.85%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $81.96
Upside: +15.91%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $19.72
Upside: +82.56%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $6.72
Upside: +569.64%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $8.64
Upside: +1,288.89%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $4.49
Upside: +568.90%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $19.02
Upside: -31.65%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $15.16
Upside: +177.04%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $566.36
Upside: -59.39%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $351.47
Upside: -34.56%